CN1267456C - Process for preparing glucose-reducing sand sagebrush polysaccharide and its use - Google Patents
Process for preparing glucose-reducing sand sagebrush polysaccharide and its use Download PDFInfo
- Publication number
- CN1267456C CN1267456C CN 200510002228 CN200510002228A CN1267456C CN 1267456 C CN1267456 C CN 1267456C CN 200510002228 CN200510002228 CN 200510002228 CN 200510002228 A CN200510002228 A CN 200510002228A CN 1267456 C CN1267456 C CN 1267456C
- Authority
- CN
- China
- Prior art keywords
- diabetes
- artemisia
- hypoglycemic
- preparation
- substance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000004676 glycans Chemical class 0.000 title claims abstract description 19
- 229920001282 polysaccharide Polymers 0.000 title claims abstract description 19
- 239000005017 polysaccharide Substances 0.000 title claims abstract description 19
- 235000015702 Artemisia filifolia Nutrition 0.000 title claims 7
- 241001670242 Artemisia filifolia Species 0.000 title claims 7
- 238000004519 manufacturing process Methods 0.000 title abstract description 6
- 230000002218 hypoglycaemic effect Effects 0.000 claims abstract description 32
- 206010012601 diabetes mellitus Diseases 0.000 claims abstract description 19
- 238000002360 preparation method Methods 0.000 claims abstract description 17
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims abstract description 12
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000004440 column chromatography Methods 0.000 claims abstract description 10
- 229920005654 Sephadex Polymers 0.000 claims abstract description 6
- 239000012507 Sephadex™ Substances 0.000 claims abstract description 6
- 239000002699 waste material Substances 0.000 claims abstract description 5
- 238000000605 extraction Methods 0.000 claims abstract description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 21
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 239000000126 substance Substances 0.000 claims description 15
- 239000000243 solution Substances 0.000 claims description 13
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 claims description 10
- 238000000502 dialysis Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 239000012141 concentrate Substances 0.000 claims description 8
- 230000002829 reductive effect Effects 0.000 claims description 8
- -1 D-wood sugar Chemical compound 0.000 claims description 7
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 7
- 238000004587 chromatography analysis Methods 0.000 claims description 5
- 238000000194 supercritical-fluid extraction Methods 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-STGXQOJASA-N alpha-D-lyxopyranose Chemical compound O[C@@H]1CO[C@H](O)[C@@H](O)[C@H]1O SRBFZHDQGSBBOR-STGXQOJASA-N 0.000 claims description 2
- 239000011259 mixed solution Substances 0.000 claims description 2
- 235000005492 Artemisia desertorum Nutrition 0.000 claims 4
- 241001661344 Artemisia desertorum Species 0.000 claims 4
- 238000004090 dissolution Methods 0.000 claims 2
- 238000001556 precipitation Methods 0.000 claims 2
- 230000003068 static effect Effects 0.000 claims 2
- 238000001291 vacuum drying Methods 0.000 claims 2
- LPQOADBMXVRBNX-UHFFFAOYSA-N ac1ldcw0 Chemical compound Cl.C1CN(C)CCN1C1=C(F)C=C2C(=O)C(C(O)=O)=CN3CCSC1=C32 LPQOADBMXVRBNX-UHFFFAOYSA-N 0.000 claims 1
- 230000006837 decompression Effects 0.000 claims 1
- 239000004519 grease Substances 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 238000005303 weighing Methods 0.000 claims 1
- 229960003487 xylose Drugs 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 18
- 210000004369 blood Anatomy 0.000 abstract description 18
- 235000001405 Artemisia annua Nutrition 0.000 abstract description 14
- 240000000011 Artemisia annua Species 0.000 abstract description 14
- 108090000526 Papain Proteins 0.000 abstract description 9
- 239000004365 Protease Substances 0.000 abstract description 9
- 229940055729 papain Drugs 0.000 abstract description 9
- 235000019834 papain Nutrition 0.000 abstract description 9
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 abstract description 8
- 108010082126 Alanine transaminase Proteins 0.000 abstract description 8
- 108010003415 Aspartate Aminotransferases Proteins 0.000 abstract description 8
- 102000004625 Aspartate Aminotransferases Human genes 0.000 abstract description 8
- HIMXGTXNXJYFGB-UHFFFAOYSA-N alloxan Chemical compound O=C1NC(=O)C(=O)C(=O)N1 HIMXGTXNXJYFGB-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000203 mixture Substances 0.000 abstract description 8
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 7
- 230000004580 weight loss Effects 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 5
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 210000004185 liver Anatomy 0.000 abstract description 5
- VVJYUAYZJAKGRQ-UHFFFAOYSA-N 1-[4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C(O)C1 VVJYUAYZJAKGRQ-UHFFFAOYSA-N 0.000 abstract description 3
- 206010018429 Glucose tolerance impaired Diseases 0.000 abstract description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 abstract description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 abstract description 2
- 230000003301 hydrolyzing effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 238000002481 ethanol extraction Methods 0.000 abstract 1
- 239000003480 eluent Substances 0.000 description 11
- 229930014626 natural product Natural products 0.000 description 11
- 239000002244 precipitate Substances 0.000 description 8
- 239000003814 drug Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 241000700159 Rattus Species 0.000 description 6
- 239000003472 antidiabetic agent Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 208000016261 weight loss Diseases 0.000 description 5
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 201000001421 hyperglycemia Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 241000208340 Araliaceae Species 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- 239000006286 aqueous extract Substances 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 2
- 235000003826 Artemisia Nutrition 0.000 description 2
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000132012 Atractylodes Species 0.000 description 2
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 244000302512 Momordica charantia Species 0.000 description 2
- 235000009811 Momordica charantia Nutrition 0.000 description 2
- 244000030166 artemisia Species 0.000 description 2
- 235000009052 artemisia Nutrition 0.000 description 2
- 235000015895 biscuits Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 238000005238 degreasing Methods 0.000 description 2
- 238000002296 dynamic light scattering Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 230000003345 hyperglycaemic effect Effects 0.000 description 2
- 229940126904 hypoglycaemic agent Drugs 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000001370 static light scattering Methods 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000003092 Artemisia dracunculus Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 208000031648 Body Weight Changes Diseases 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000209205 Coix Species 0.000 description 1
- 241000233779 Cyclocarya paliurus Species 0.000 description 1
- 208000002249 Diabetes Complications Diseases 0.000 description 1
- 206010012655 Diabetic complications Diseases 0.000 description 1
- 239000004366 Glucose oxidase Substances 0.000 description 1
- 108010015776 Glucose oxidase Proteins 0.000 description 1
- 241000208251 Gymnema Species 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- 240000002853 Nelumbo nucifera Species 0.000 description 1
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 1
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 1
- 244000248557 Ophiopogon japonicus Species 0.000 description 1
- 241000219784 Sophora Species 0.000 description 1
- 229940100389 Sulfonylurea Drugs 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- 229940123464 Thiazolidinedione Drugs 0.000 description 1
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 description 1
- 108010021119 Trichosanthin Proteins 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 229930101531 artemisinin Natural products 0.000 description 1
- BLUAFEHZUWYNDE-NNWCWBAJSA-N artemisinin Chemical compound C([C@](OO1)(C)O2)C[C@H]3[C@H](C)CC[C@@H]4[C@@]31[C@@H]2OC(=O)[C@@H]4C BLUAFEHZUWYNDE-NNWCWBAJSA-N 0.000 description 1
- 229960004191 artemisinin Drugs 0.000 description 1
- 235000006533 astragalus Nutrition 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000004579 body weight change Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 229940105329 carboxymethylcellulose Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000000451 gelidium spp. gum Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229930182494 ginsenoside Natural products 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940116332 glucose oxidase Drugs 0.000 description 1
- 235000019420 glucose oxidase Nutrition 0.000 description 1
- 239000010651 grapefruit oil Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 210000004153 islets of langerhan Anatomy 0.000 description 1
- 229940118019 malondialdehyde Drugs 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 235000021179 potluck Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229960002718 selenomethionine Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- YROXIXLRRCOBKF-UHFFFAOYSA-N sulfonylurea Chemical class OC(=N)N=S(=O)=O YROXIXLRRCOBKF-UHFFFAOYSA-N 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
本发明涉及一种以天然沙蒿种子脱去油后的废渣为原料,经过提取、分离、酶解、柱层析制备的沙蒿多糖及其制备方法和应用,其特征是用50-80%乙醇提取,氯仿和正丁醇混合液进行萃取,木瓜蛋白酶进行酶解、通过sephadex G-200柱层析而获得,用于治疗四氧嘧啶引起的化学型糖尿病,减少糖尿病对肝脏、肾脏的受损,降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,并能抑制糖尿病导致体重的减轻,生产工艺简单,降糖效果好,无毒副作用,使用方便,用于治疗糖尿病效果良好。The invention relates to a kind of Artemisia annua polysaccharide prepared by extracting, separating, enzymatically hydrolyzing and column chromatography using waste residue after removing oil from natural Artemisia annua seeds as raw material, and its preparation method and application, which is characterized in that it uses 50-80% Ethanol extraction, chloroform and n-butanol mixture for extraction, papain enzymatic hydrolysis, obtained through sephadex G-200 column chromatography, used to treat chemical diabetes caused by alloxan, and reduce the damage of diabetes to the liver and kidney , reduce blood aspartate aminotransferase, alanine aminotransferase, urea nitrogen content, and can inhibit weight loss caused by diabetes, simple production process, good hypoglycemic effect, no toxic side effects, easy to use, good effect for treating diabetes.
Description
技术领域technical field
本发明涉及一种以天然沙蒿种子脱去油后的废渣为原料,经过提取、分离、酶解、柱层析制备的具有降糖作用的沙蒿多糖制备方法及其应用。The invention relates to a method for preparing Artemisia annua polysaccharide with hypoglycemic effect, which is prepared by extracting, separating, enzymatically hydrolyzing and column chromatography using the waste residue after removing oil from natural Artemisia annua seeds and its application.
背景技术Background technique
糖尿病是一种与遗传因素和多种环境因素相关联的以慢性高血糖为特征的代谢紊乱综合症,是一种全球范围内的严重危害人类健康的常见疾病。近年来,全球糖尿病患病率及死亡率都呈现一个逐步上升趋势,成为当今世界医学界亟待解决和攻克的重点课题之一。常用降糖药是以合成药物为主的制剂,对肝肾有一定的损伤,不易为患者接受。Diabetes mellitus is a metabolic disorder syndrome characterized by chronic hyperglycemia associated with genetic factors and various environmental factors. It is a common disease that seriously endangers human health worldwide. In recent years, the prevalence and mortality of diabetes in the world have shown a gradual upward trend, and it has become one of the key issues to be solved and overcome in the world's medical field today. Commonly used hypoglycemic drugs are mainly synthetic drugs, which have certain damage to the liver and kidney and are not easily accepted by patients.
专利JP95/00560申请了具有降血糖作用新的吡啶型噻唑烷化合物及其盐;专利CN86104075(86104075)申请了降血糖药物--噻唑烷二酮类的制备方法,它们在治疗高血糖动物中的应用方法以及含有它们的药物配方;专利CN1252273(99121819.1)申请了新一代磺脲类降血糖药-硒代蛋氨酸铬磺脲类降血糖药的制备和应用;专利CN1465342(02112414.0)申请了一种噻唑烷盐类衍生物降血糖药物;CN1113491(95102055.2)通过选择性还原适宜的1-(2-,3-或4-硝基苯磺酰)衍生物制备具有降血糖活性的新的羟胺化合物。Patent JP95/00560 applied for a new pyridine-type thiazolidine compound and its salt with hypoglycemic effect; patent CN86104075 (86104075) applied for the preparation method of hypoglycemic drugs-thiazolidinedione, and they are effective in treating hyperglycemic animals. Application methods and pharmaceutical formulations containing them; patent CN1252273 (99121819.1) applied for the preparation and application of a new generation of sulfonylurea hypoglycemic agents-selenomethionine chromium sulfonylurea hypoglycemic agents; patent CN1465342 (02112414.0) applied for a thiazole Alkyl salt derivative hypoglycemic drug; CN1113491 (95102055.2) prepares new hydroxylamine compound with hypoglycemic activity by selectively reducing suitable 1-(2-, 3- or 4-nitrobenzenesulfonyl) derivatives.
专利US20030072822申请了一种龙蒿乙醇提取物治疗糖尿病的方法;专利US20040151783申请了一种具有降血糖作用的森林匙羹藤叶多糖成分;专利US20030054015申请了一种可兴奋交感神经的香精的成分,其中柚子油对糖尿病患者具有降血糖效果。专利US20030198697申请了一种从薏苡中提取的脂肪酸成分,具有降血糖作用。专利CN1188651(97100285.1)从野生的石莲花中提取的含有降血糖有效成分的一种高效纯天然的降血糖保健品或药品;专利CN1151303(95117499.1)申请了一种以景天科燕子掌等植物为原料提取降血糖与营养物质的新工艺;专利CN1137411(95105954.8)申请了一种由人参、蛤蚧等12种中药组成的康复胰岛降血糖的中药“康复胰岛降糖丹”及制作方法;专利CN1401318(02138749.4)从中药鬼箭羽中提取、分离具有降血糖作用的有效部位及有效成分,包含萜类、酚酸类等,具有降糖尿病小鼠血糖作用,同时影响丙二醛及超氧化物歧化酶,能够减轻或抑制糖尿病并发症的发生和发展;专利CN1456337(03128089.7)申请了一种含多个降血糖活性成分的苦瓜制品及制备方法;专利CN1306752(00101247.9)公开了一种具有降血糖作用的食用保健饼干一缮食纤维百乐饼干的配方及生产工艺。该饼干主要含有面粉、膳食纤维、活性多糖、山药、苦瓜等,经科学方法研制而成。Patent US20030072822 applied for a method of ethanol extract of tarragon to treat diabetes; patent US20040151783 applied for a polysaccharide component of Gymnema sylvestris leaf with hypoglycemic effect; Among them, grapefruit oil has a hypoglycemic effect on diabetic patients. Patent US20030198697 applied for a fatty acid component extracted from coix, which has hypoglycemic effect. Patent CN1188651 (97100285.1) extracts a kind of high-efficiency pure natural hypoglycemic health care product or medicine containing hypoglycemic active ingredients extracted from wild stone lotus; A new technology for extracting blood sugar and nutrients from raw materials; patent CN1137411 (95105954.8) applied for a Chinese medicine "Rehabilitation Pancreatic Islet Hypoglycemic Pill" composed of 12 kinds of traditional Chinese medicines such as ginseng and gecko and its production method; patent CN1401318 ( 02138749.4) Extracting and separating the effective parts and active ingredients with hypoglycemic effect from the traditional Chinese medicine Guijianyu, including terpenoids, phenolic acids, etc., which have the effect of reducing blood sugar in diabetic mice, and at the same time affect malondialdehyde and superoxide dismutase , can reduce or inhibit the occurrence and development of diabetic complications; patent CN1456337 (03128089.7) applied for a bitter melon product containing multiple hypoglycemic active ingredients and its preparation method; patent CN1306752 (00101247.9) disclosed a Edible health biscuits—the formula and production process of food fiber potluck biscuits. The biscuit mainly contains flour, dietary fiber, active polysaccharide, yam, bitter gourd, etc., and is developed through scientific methods.
专利PCT/KR98/00325申请了一种作为降血糖剂的如分子式(I)的生物类黄酮或含有同样生物类黄酮的植物提取物的降低哺乳动物血糖水平的用途;专利CN1348762(00116167.9)用苦参黄酮制备治疗糖尿病的药剂,和用苦参黄酮与黄芪多糖、人参多糖、人参总甙、麦冬多糖、天花粉多糖、桑叶总多糖有效成分中的至少一种制备治疗糖尿病的复方药剂;专利CN1389146(02138749.4)将青钱柳提取物,配以风味剂,辅助物质,并加入海藻酸钠、羧甲基纤维素、琼脂、黄原胶中两种或两种以上物质作为稳定剂,制得的降血糖、降血压、降血脂保健食品;专利CN1245060(98110398.7)将(1)L-肉碱,(2)壳聚糖,(3)富铬微生物多糖份按一定配方组合在一种高效减肥及降血糖药品或保健食品的制备方法;专利CN1398630(02136740.X)从中药材白术中提取具有降血糖活性的糖复合物、其生产方法和用途。国内外专利均未涉及沙蒿多糖为原料的降糖天然产物的制备方法及应用。Patent PCT/KR98/00325 has applied for a kind of as hypoglycemic agent as the bioflavonoid of molecular formula (I) or the purposes that the plant extract that contains same bioflavonoid reduces the blood sugar level of mammal; Patent CN1348762 (00116167.9) uses bitter Preparation of medicaments for treating diabetes from ginseng flavonoids, and preparation of compound medicaments for treating diabetes by using at least one of the active ingredients of sophora flavonoids and astragalus polysaccharides, ginseng polysaccharides, ginsenosides, Ophiopogon japonicus polysaccharides, trichosanthin polysaccharides, and mulberry leaf total polysaccharides; patent CN1389146 (02138749.4) extract of Cyclocarya paliurus, together with flavoring agent and auxiliary substances, and add two or more substances in sodium alginate, carboxymethyl cellulose, agar, and xanthan gum as stabilizers to obtain Hypoglycemic, blood pressure, and blood fat-lowering health food; patent CN1245060 (98110398.7) combines (1) L-carnitine, (2) chitosan, (3) chromium-rich microbial polysaccharides in a high-efficiency weight-loss diet according to a certain formula And the preparation method of hypoglycemic medicine or health food; the patent CN1398630 (02136740.X) extracts the sugar complex with hypoglycemic activity from the Chinese medicinal material Atractylodes Rhizoma Atractylodes Rhizome, its production method and application. None of the patents at home and abroad involve the preparation method and application of the hypoglycemic natural product made of artemisia polysaccharide as raw material.
发明内容Contents of the invention
本发明的目的是以沙蒿脱去油后的废渣为原料,经过提取、分离、酶解、柱层析等制备的一种天然的能降低血糖,并能减少糖尿病造成的对肝脏、肾脏的损伤即降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,以及抑制糖尿病导致体重减轻的天然生物多糖沙蒿多糖及其制备方法和应用。The purpose of the present invention is to use the waste residue after degreasing of Artemisia annua as raw material, and prepare a kind of natural can reduce blood sugar through extraction, separation, enzymolysis, column chromatography, etc., and can reduce the damage to liver and kidney caused by diabetes. The damage is to reduce the contents of aspartate aminotransferase, alanine aminotransferase and urea nitrogen in the blood, as well as the natural biological polysaccharide Artemisia polysaccharide that inhibits weight loss caused by diabetes, and its preparation method and application.
本发明的步骤如下,The steps of the present invention are as follows,
步骤1:沙蒿种子经CO2超临界萃取脱去油脂后,用水充分溶解,原料与水的比例为1∶30-50,在水溶液中加入乙醇,乙醇含量达到50-80%后静止、过夜、离心,收集沉淀,真空干燥得物质A;Step 1: After the Artemisia annua seeds are degreased by CO2 supercritical extraction, fully dissolve in water, the ratio of raw materials to water is 1:30-50, add ethanol to the aqueous solution, and let the ethanol content reach 50-80%, then stand still and stay overnight , Centrifuge, collect the precipitate, and vacuum-dry to obtain substance A;
步骤2:称取一定重量的物质A,用80-100倍重量的水溶解,在水溶液中加入木瓜蛋白酶进行酶解,再用1∶2-4氯仿和正丁醇混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: Weigh a certain weight of substance A, dissolve it with 80-100 times the weight of water, add papain to the aqueous solution for enzymatic hydrolysis, then extract with a 1:2-4 mixture of chloroform and n-butanol, and collect the water layer The solution was concentrated under reduced pressure and dried to obtain substance B, the volume ratio of the aqueous solution of A and the extract was 4:1, and the amount of papain was 24.00U/2000ml of aqueous solution;
步骤3:将物质B通过sephadex G-200柱层析,洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml,洗脱液减压浓缩后放入透析袋中透析36-48h,透析液加入2-3倍量乙醇静止、过夜、离心,收集沉淀,真空干燥得纯沙蒿种子天然生物多糖。Step 3: Pass substance B through sephadex G-200 column chromatography, eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography, concentrate under reduced pressure and release Put it into a dialysis bag for dialysis for 36-48 hours, add 2-3 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate, and dry it in vacuum to obtain the natural biopolysaccharide of pure Artemisia annua seeds.
分子量、化学组成:分子量Mn约为1.42×105g/mol,第二维利系数是3.64×10-5cm3mol/g2;由L-阿拉伯糖、D-木糖、D-来苏糖、D-甘露糖、D-葡萄糖、D-半乳糖等六种单糖组成,摩尔比为0.14∶0.09∶1.51∶0.17∶0.07∶1.45,白色粉末。Molecular weight and chemical composition: the molecular weight Mn is about 1.42×10 5 g/mol, and the second Veliy coefficient is 3.64×10 -5 cm 3 mol/g 2 ; it consists of L-arabinose, D-xylose, and D-lysol Sugar, D-mannose, D-glucose, D-galactose and other six monosaccharides, the molar ratio is 0.14:0.09:1.51:0.17:0.07:1.45, white powder.
此天然生物多糖主要用于治疗化学性糖尿病,并能减少糖尿病对肝、肾的损伤等经对大鼠药理实验表明:30天喂养该制剂使高血糖动物的血糖降低13.98%,谷丙转氨酶(GPT)降低25.48%、谷草转氨酶(GOT)降低28.7%、尿素氮含量降低51.27%、显著减缓糖尿病引起的体重下降。This natural biological polysaccharide is mainly used to treat chemical diabetes, and can reduce the damage of diabetes to liver and kidney, etc. Pharmacological experiments on rats showed that feeding the preparation for 30 days reduced the blood sugar of hyperglycemic animals by 13.98%, alanine aminotransferase ( GPT) decreased by 25.48%, aspartate transaminase (GOT) decreased by 28.7%, blood urea nitrogen content decreased by 51.27%, and the weight loss caused by diabetes was significantly slowed down.
本发明的特点:本发明以沙蒿脱去油后的废渣为原料,经过提取、分离、酶解、柱层析等制备的一种天然的能降低血糖,并能减少糖尿病对肝脏、肾脏的损伤即降低血液中谷草转氨酶、谷丙转氨酶、尿素氮的含量,并能抑制糖尿病导致体重减轻的制剂。与其它降糖药相比具有生产工艺简单,降糖效果好,无毒副作用,使用方便,对I型、II型糖尿病等都有较好的疗效。The characteristics of the present invention: the present invention uses the waste residue after degreasing of Artemisia annua as raw material, and prepares a kind of natural blood sugar that can lower blood sugar and reduce the damage of diabetes to the liver and kidney through extraction, separation, enzymolysis, column chromatography, etc. Injuries are preparations that reduce the levels of aspartate aminotransferase, alanine aminotransferase, and urea nitrogen in the blood, and can inhibit weight loss caused by diabetes. Compared with other hypoglycemic drugs, it has the advantages of simple production process, good hypoglycemic effect, no toxic and side effects, convenient use, and good curative effect on type I and type II diabetes.
具体实施方式Detailed ways
实施例1:Example 1:
沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds
步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶30),在水溶液中加入乙醇(乙醇含量达到50%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: The part of Artemisia annua seeds degreased by CO2 supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:30), and ethanol is added to the aqueous solution (the ethanol content reaches 50%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;
步骤2:称取一定重量的物质A用80倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶2)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1,木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in water with 80 times its weight, add papain to the water solution for enzymolysis, then extract with chloroform and n-butanol (1:2) mixture, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the volume ratio of A aqueous solution and extract is 4:1, and the amount of papain is 24.00U/2000ml aqueous solution;
步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析36h,透析液加入2倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 36 hours, add 2 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain a pure hypoglycemic natural product.
降糖作用:四氧嘧啶引起的化学型糖尿病大鼠服用本品后血液中血糖、谷丙转氨酶、谷草转氨酶、尿素氮均降低结果如下表:Hypoglycemic effect: Alloxan-induced chemical diabetic rats took this product and the blood sugar, alanine aminotransferase, aspartate aminotransferase, and urea nitrogen all decreased. The results are shown in the following table:
体重变化:每组体重平均值见(表1),对照组体重增加,高血糖组体重明显降低,降低率为7.69%,而喂纯天然沙蒿多糖组的糖尿病大鼠个体体重略减轻,降低率为1.56%,说明其对高血糖个体体重的减轻有一定的抑制作用。Body weight change: the average weight of each group is shown in (Table 1). The weight of the control group increased, and the body weight of the hyperglycemia group decreased significantly, with a reduction rate of 7.69%. The rate is 1.56%, indicating that it has a certain inhibitory effect on the weight loss of individuals with high blood sugar.
表1 实验各组大鼠体重(g/只)
利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成。The molecular weight and chemical composition of pure hypoglycemic natural products were characterized by dynamic and static light scattering, gas chromatography, infrared spectroscopy, and nuclear magnetic resonance.
动静态光散射仪、气相色谱证实:纯降糖天然产物重均分子量Mn约为1.42×105g/mol,第二维利系数是3.64×10-5cm3mol/g2;由L-阿拉伯糖、D-木糖、D-来苏糖、D-甘露糖、D-葡萄糖、D-半乳糖等六种单糖组成,摩尔比为0.14∶0.09∶1.51∶0.17∶0.07∶1.45,白色粉末。Dynamic and static light scattering instrument and gas chromatography confirmed that the weight-average molecular weight Mn of the pure hypoglycemic natural product is about 1.42×10 5 g/mol, and the second Veliy coefficient is 3.64×10 -5 cm 3 mol/g 2 ; Composed of six monosaccharides including arabinose, D-xylose, D-lyxose, D-mannose, D-glucose, and D-galactose, the molar ratio is 0.14:0.09:1.51:0.17:0.07:1.45, white powder.
葡萄糖(Glu)用葡萄糖氧化酶法测定、谷丙转氨酶(GPT)与谷草转氨酶(GOT)分别用连续检测法测定,尿素氮(BuN)使用终点法测定等指标。仪器使用全自动生化分析仪,OLYcupus AU400型(日本)。四氧嘧啶购自sigma公司产品。Glucose (Glu) was determined by glucose oxidase method, alanine aminotransferase (GPT) and aspartate aminotransferase (GOT) were determined by continuous detection method, and urea nitrogen (BuN) was determined by endpoint method. The instrument uses a fully automatic biochemical analyzer, OLYcupus AU400 (Japan). Alloxan was purchased from sigma company.
服用本品后使四氧嘧啶引起的化学型糖尿病动物的血糖、谷丙转氨酶、谷草转氨酶、尿素氮含量均降低,表明降糖效果较好。After taking this product, the blood sugar, alanine aminotransferase, aspartate aminotransferase, and urea nitrogen content of alloxan-induced chemical diabetic animals were all reduced, indicating that the hypoglycemic effect is better.
实施例2:Example 2:
沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds
步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶50),在水溶液中加入乙醇(乙醇含量达到80%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: Part of Artemisia annua seeds degreased by CO2 supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:50), and ethanol is added to the aqueous solution (the ethanol content reaches 80%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;
步骤2:称取一定重量的物质A用100倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶4)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in 100 times the weight of water, add papain to the water solution for enzymolysis, then extract with chloroform and n-butanol (1:4) mixture, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the ratio of A aqueous solution and extract is 4:1 by volume, and the amount of papain is 24.00U/2000ml aqueous solution;
步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析48h,透析液加入3倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 48 hours, add 3 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain the pure hypoglycemic natural product.
大鼠试验结果与实施例1同,利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成与实施例1同。The results of the rat test are the same as in Example 1, and the molecular weight and chemical composition of the pure hypoglycemic natural product are the same as in Example 1.
实施例3:Example 3:
沙蒿种子中降糖天然产物的制备方法及其应用Preparation method and application of hypoglycemic natural product from Artemisia annua seeds
步骤1:沙蒿种子经CO2超临界萃取脱去油脂后的部分用水充分溶解(原料与水的比例为1∶40),在水溶液中加入乙醇(乙醇含量达到70%)静止、过夜、离心,收集沉淀真空干燥得物质A;Step 1: Part of Artemisia annua seeds degreased by CO supercritical extraction is fully dissolved in water (the ratio of raw material to water is 1:40), and ethanol is added to the aqueous solution (the ethanol content reaches 70%) to stand still, overnight, and centrifuged , collect the precipitate and dry it in vacuum to obtain substance A;
步骤2:称取一定重量的物质A用90倍重量的水溶解,在水溶解中加入木瓜蛋白酶进行酶解,再用氯仿和正丁醇(1∶3)混合液进行萃取,收集水层溶液减压浓缩、干燥得物质B,A水溶液与萃取液按体积比比例为4∶1、木瓜蛋白酶用量为24.00U/2000ml水溶液;Step 2: take a certain weight of material A and dissolve it in water with 90 times its weight, add papain in the water solution to carry out enzymolysis, then extract with chloroform and n-butanol (1:3) mixed solution, collect the aqueous layer solution to reduce Concentrate under pressure and dry to obtain substance B, the ratio of A aqueous solution and extract is 4:1 by volume, and the amount of papain is 24.00U/2000ml aqueous solution;
步骤3:将物质B通过sephadex G-200柱层析(洗脱液为:0.05molNacl溶液,流速:8ml/h,收集层析后洗脱液每份1.5ml),洗脱液减压浓缩后放入透析袋中透析36-48h,透析液加入2.5倍量乙醇静止、过夜、离心,收集沉淀真空干燥得纯降糖天然产物。Step 3: Pass substance B through sephadex G-200 column chromatography (eluent: 0.05molNacl solution, flow rate: 8ml/h, collect 1.5ml of eluent after chromatography), and concentrate the eluent under reduced pressure Put it into a dialysis bag for dialysis for 36-48 hours, add 2.5 times the amount of ethanol to the dialysate, let it stand overnight, centrifuge, collect the precipitate and dry it in vacuum to obtain the pure hypoglycemic natural product.
大鼠试验结果与实施例1同,利用动静态光散射仪、气相色谱、红外光谱、核磁共振等表征纯降糖天然产物的分子量和化学组成与实施例1同。The results of the rat test are the same as in Example 1, and the molecular weight and chemical composition of the pure hypoglycemic natural product are the same as in Example 1.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510002228 CN1267456C (en) | 2005-01-18 | 2005-01-18 | Process for preparing glucose-reducing sand sagebrush polysaccharide and its use |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200510002228 CN1267456C (en) | 2005-01-18 | 2005-01-18 | Process for preparing glucose-reducing sand sagebrush polysaccharide and its use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1654481A CN1654481A (en) | 2005-08-17 |
| CN1267456C true CN1267456C (en) | 2006-08-02 |
Family
ID=34894102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200510002228 Expired - Fee Related CN1267456C (en) | 2005-01-18 | 2005-01-18 | Process for preparing glucose-reducing sand sagebrush polysaccharide and its use |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1267456C (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100553496C (en) * | 2006-06-02 | 2009-10-28 | 中国科学院长春应用化学研究所 | A kind of preparation process of sand sage gelatin diet |
| CN101219157B (en) * | 2007-11-16 | 2010-12-08 | 西北师范大学 | A kind of preparation method of blood sugar lowering product |
| CN101240036B (en) | 2008-02-26 | 2010-06-09 | 西北师范大学 | A method for microwave-assisted extraction of Artemisia polysaccharides |
| CN100572397C (en) * | 2008-05-07 | 2009-12-23 | 西北师范大学 | A kind of preparation method of lily polysaccharide of strengthening immunity |
| CN101412762B (en) * | 2008-12-10 | 2011-01-05 | 西北师范大学 | Method for catalytically synthesizing sand sagebrush polysaccharide sulfate |
| CN102268101A (en) * | 2011-08-31 | 2011-12-07 | 南京财经大学 | Enzyme-assisted extraction method of high-purity porphyra polysaccharide |
| CN102987206A (en) * | 2012-12-27 | 2013-03-27 | 上海普维健康食品有限公司 | Composition capable of reducing blood glucose |
| CN103156865B (en) * | 2013-03-14 | 2015-12-23 | 广西壮族自治区中国科学院广西植物研究所 | L-arabinose is preparing the application in medicine or health product |
| CN106397622B (en) * | 2016-10-11 | 2018-10-02 | 重庆三峡医药高等专科学校 | The extraction of bulbus fritillariae cirrhosae polysaccharide and separation purifying technique |
| CN114644719A (en) * | 2022-03-24 | 2022-06-21 | 珠海中科先进技术研究院有限公司 | Hai antler polysaccharide extracting solution and preparation method and application thereof |
-
2005
- 2005-01-18 CN CN 200510002228 patent/CN1267456C/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN1654481A (en) | 2005-08-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3275456B1 (en) | Pharmaceutical composition containing silibinin and pueraria root extract | |
| CN101357952A (en) | A kind of mussel polysaccharide MA with hypolipidemic activity and preparation method thereof | |
| CN1267456C (en) | Process for preparing glucose-reducing sand sagebrush polysaccharide and its use | |
| CN113425764A (en) | Application of herba cistanches Deserticolae total glycosides and echinacoside in preparing medicine for preventing and treating alcoholic liver injury and intestinal injury | |
| CN104997883A (en) | Inonotus obliquus raspberry tree red raspberry composition, inonotus obliquus raspberry tree red raspberry composite oral solution and preparation method and application thereof | |
| CN111568945A (en) | Compound cyclocarya paliurus preparation | |
| CN112961262A (en) | Passiflora edulis pericarp acidic polysaccharide, preparation method and application thereof | |
| CN104288344B (en) | Application of Pu' er tea extract in preparation of medicine or food for regulating intestinal flora and relaxing bowels | |
| CN113694104B (en) | Traditional Chinese medicine composition with protection effect on chemical liver injury and liver regeneration promotion function, preparation method and application thereof | |
| CN107266599B (en) | Flammulina velutipes polysaccharide, extraction method and application thereof in preparation of medicine for treating functional constipation | |
| CN1965915A (en) | Method for extracting bitter buckwheat flavone in high purity | |
| CN106265717B (en) | Application of the dicliptera chinensis polysaccharide in preparing prevention diabetes medicament or health products | |
| JP3966727B2 (en) | Drugs made from aged kyoto extract | |
| CN113332395A (en) | Traditional Chinese medicine composition for treating type 2 diabetes and preparation method thereof | |
| CN106109554A (en) | A kind of compositions improving insulin resistant | |
| CN113521186B (en) | Hypoglycemic drug and preparation method and application thereof | |
| CN119185417B (en) | Composition for promoting blood circulation, reducing turbidity and preventing myocardial infarction, as well as preparation method and application thereof | |
| CN101219157B (en) | A kind of preparation method of blood sugar lowering product | |
| CN114292343B (en) | A method for preparing exopolysaccharide and intracellular polysaccharide of Perennial ash and its application in regulating intestinal microbial flora and lowering blood sugar | |
| CN101744989B (en) | Method for extracting schisandra chinensis, ginseng and dwarf lilyturf root and preparation thereof | |
| CN1919875A (en) | Cryptoporus volvatus polysaccharide, preparation and application thereof | |
| CN112121056A (en) | The use of the composition of small molecule fucoidan and phycoxanthin for preparing the composition for improving non-alcoholic fatty liver | |
| CN101040647A (en) | Mulberry leaf tea and its preparing process | |
| Al-Okbi et al. | Assessment of the safety of use of certain natural anti-inflammatory agents and their effects on nutritional status in adult and growing rats | |
| CN103301243B (en) | Application of pharmaceutical composition in preparation of drugs for preventing or treating fatty liver |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20060802 Termination date: 20110118 |